Tissue generation with growth factors

• Published in: Surgery Vol. 114; no. 2; p. 374
• Main Authors: Khouri, R K, Koudsi, B, Deune, E G, Hong, S P, Ozbek, M R, Serdar, C M, Song, S Z, Pierce, G F
• Format: Journal Article
• Language: English
• Published: United States 01.08.1993
• Subjects: Animals; Apoptosis; Cell Division - drug effects; Culture Techniques; Male; Platelet-Derived Growth Factor - pharmacology; Rats; Rats, Inbred Lew; Recombinant Proteins - pharmacology
• ISSN: 0039-6060

An in vivo experimental model was introduced to determine whether the mitogenic effect of recombinant platelet-derived growth factor (rPDGF) could be used to generate potentially useful tissue. In Lewis rats, the extended femoral arteriovenous bundle was placed within silicone chambers containing collagen disks. The disks could deliver their content of rPDGF-BB (125 to 131 micrograms/disk) either as a rapid pulse or as a slow release. The time course of tissue generation was determined by harvesting the specimens at various postoperative days. The effect of continuous versus pulsed delivery was determined at 30 days. Analysis of the generated tissue was performed by use of histomorphometry. Pulsed delivery of rPDGF-BB induced the formation of a substantial amount of tissue that peaked at 10 to 15 days (145.9 +/- 13.8 vs 35.0 +/- 6.8 mm3, p < 0.0001); however, the generated tissue completely subsided by day 30. Sustained delivery of rPDGF-BB caused continuous growth of the tissue and was more effective than pulsed delivery. In an experimental model that approximates an in vivo tissue culture system, rPDGF-BB can induce a tenfold increase in tissue within the chamber. However, that tissue is labile and its survival necessitates continuous rPDGF-BB delivery. To become useful for reconstructive purposes, means to stabilize this new tissue growth are needed.